跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT01756664
NCT01756664Unknown不适用

The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing - A Pilot Study.

Mahidol University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年8月最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
干预措施

试验速览

阶段
不适用
入组人数
20
试验地点
2
主要终点
Melanin Index
研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

  • The use of sunscreen on the first day after fractional ablative skin resurfacing may reduce the risk of post-inflammatory hyperpigmentation

详细描述

  • The use of sunscreen on the first day after fractional ablative skin resurfacing may reduce the risk of post-inflammatory hyperpigmentation (PIH)
  • Therefore, we conducted the study to evaluate the efficacy of the use of sunscreen on the first day after fractional ablative skin resurfacing in reducing the risk of PIH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —（Adult, Older Adult）
性别
All
接受健康志愿者
是

入选标准

  • •Patients who want to receive fractional ablative laser resurfacing for acne scars

排除标准

  • •Pregnancy
  • •Lactation
  • •Age < 18

研究组 & 干预措施

Control

Placebo Comparator

Vaseline has been used on the first day after laser treatment

干预措施: Vaseline (Other)

Sunscreen

Active Comparator

Sunscreen has been used on the first day after laser treatment

干预措施: Sunscreen (Other)

结局指标

主要结局

Melanin Index

时间窗: 3 Month

次要结局

  • Erythema Index(3 Months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)Cutaneous Lupus Erythematosus
NCT01146444Spirig Pharma Ltd.20
已完成
不适用
Two Consecutive Sunscreen Applications Optimize Sun ProtectionSun Protection
NCT03033654Bispebjerg Hospital31
已完成
不适用
Prevention of Melasma Relapse During SummertimeMelasma
NCT02061839Centre de Pharmacologie Clinique Applique a la Dermatologie40
已完成
3 期
Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for CancerDermatologic ComplicationsUnspecified Adult Solid Tumor, Protocol Specific
NCT00362986Alliance for Clinical Trials in Oncology116
尚未招募
不适用
To determine the efficacy of sunscreens in the treatment of melasma as assessed(measured) by Melasma Quality of life
CTRI/2016/05/006965Indian Association of Dermatologists Venereologists and LeprologistsIADV100